Tactile Systems Technology, Inc. (TCMD)

NASDAQ: TCMD · USD

$23.9

+0.42 (+1.8%)· Recorded snapshot

Market cap	540.9M
Revenue (ttm)	350.3M
Net income (ttm)	24.9M
EPS (ttm)	$1.08
Shares out	22.7M
P/E (trailing)	22.1x
P/E (forward)	19.9x
Volume	99,202
Beta	0.82

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 350.3M
Net income (ttm): 24.9M
EPS (ttm): $1.08
P/E (trailing): 22.1x
P/E (forward): 19.9x
Market cap: 540.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.9

P25 n/aP50 n/aP75 n/a

Trailing P/E22.1

P25 n/aP50 n/aP75 n/a

ROE11.9

P25 n/aP50 n/aP75 n/a

ROIC14.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TCMD indicators

Market & fundamental data

Available fields

265

Groups with data

Currency

USD

Showing 265 of 265 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001027838
Company name	Tactile Systems Technology, Inc.
Country	United States
Country code	US
CUSIP number	87357P100
Earnings date	2026-11-02
Earnings time	amc
Employees	1,086
Employees change	49
Employees growth	4.73%
Enterprise value	$485.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1995
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2016-07-28
Is primary listing	Yes
Is SPAC	No
ISIN number	US87357P1003
Last 10-K release date	2026-02-17
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$540.9M
Market cap category	Small-Cap
Next earnings date	2026-11-02
Options	Yes
Price	$23.88
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	TCMD
U.S. state	Minnesota
Website	https://tactilemedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	20.2x
Average P/E ratio (10Y)	292.79x
Average P/E ratio (3Y)	19.7x
Average P/E ratio (5Y)	141.17x
Earnings yield	4.53%
EV/Earnings	19.67x
EV/EBIT	13.96x
EV/EBITDA	11.72x
EV/FCF	18.24x
EV/Sales	1.4x
FCF / EV yield	5.48%
FCF yield	4.92%
Forward EV/Sales	1.3x
Forward P/E	19.92x
Forward P/S	1.45x
Graham number	15.4838
Graham upside	-35.6%
Industry forward P/E	19.81x
Industry P/E	39.28x
Lynch fair value	$13.90
Lynch upside	-42.18%
P/(FCF - SBC) ratio	29.56x
P/(OCF - SBC) ratio	24.58x
P/B ratio	2.38x
P/E ratio	22.1x
P/FCF ratio	20.31x
P/OCF ratio	17.83x
P/S ratio	1.55x
Price / tangible book value	3.9x
Price/EBITDA ratio	13.05x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	10%
EBITDA margin	11.91%
Effective tax rate	33.44%
FCF margin	7.66%
Gross margin	76.78%
Operating margin	10%
Pretax margin	10.66%
Profit margin	7.1%
Profit per employee	$22,896
Profitable quarters	1
Profitable years	3
Revenue per employee	$322,573
ROA	7.92%
ROA (5Y)	2.85%
ROCE	14.51%
ROE	11.88%
ROE (5Y)	2.3%
ROIC	14.29%
ROIC (5Y)	5.55%
SBC / revenue	2.4%
Tax / revenue	3.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	72.86%
EPS growth (Q)	144.06%
EPS growth 10Y	33.09%
EPS growth 3Y	328.45%
EPS growth 5Y	9.22%
EPS growth quarters	4
EPS growth years	1
FCF growth	-32.29%
FCF growth (Q)	-86.29%
FCF growth 3Y	16.36%
FCF growth 5Y	31.37%
Gross profit growth	20.46%
Gross profit growth (Q)	11.15%
Gross profit growth 3Y	12.55%
Gross profit growth 5Y	13.36%
Net income growth	64.52%
Net income growth (Q)	142%
Net income growth 3Y	311.83%
Net income growth 5Y	12.87%
Net income growth quarters	4
Net income growth years	1
OCF growth	-26.84%
OCF growth (Q)	-77.95%
OCF growth 10Y	23.7%
OCF growth 3Y	16.11%
OCF growth 5Y	28.1%
Operating income growth	85.96%
Operating income growth (Q)	67.18%
Operating income growth 3Y	51.81%
Operating income growth 5Y	47.45%
Revenue growth	17.22%
Revenue growth (Q)	8.61%
Revenue growth (QoQ)	13.86%
Revenue growth 10Y	17.24%
Revenue growth 3Y	9.56%
Revenue growth 5Y	11.62%
Revenue growth quarters	21
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-3.7M
Depreciation and amortization	$6.7M
EBIT	$35M
EBITDA	$41.7M
EPS	$1.08
FCF per share	$1.18
Financing cash flow	$-29.1M
Free cash flow	$26.8M
Free cash flow minus SBC	$18.4M
Gross profit	$269M
Income taxes	$12.5M
Investing cash flow	$-13.1M
Net borrowing	$-24.8M
Net cash flow	$-11.7M
Net income	$24.9M
Operating cash flow minus SBC	$22.2M
Operating income	$35M
Revenue	$350.3M
Stock-based compensation	$8.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	7.77
Book value per share	$9.86
Debt / EBITDA	0.32
Debt / equity	0.06
Debt / FCF	0.54
Goodwill	$39.6M
Interest coverage	139.56
Long-term assets	$122.1M
Long-term liabilities	$17.6M
Net cash (debt)	$55.5M
Net cash / market cap	10.19%
Net cash growth	41%
Net debt / EBITDA	-1.33
Net debt / equity	-0.25
Net debt / FCF	-2.07
Piotroski F-Score	7
Property, plant and equipment	$18.4M
Shareholders' equity	$223.8M
Tangible book value	$139.5M
Tangible book value per share	$6.15
Total assets	$279.7M
Total cash	$69.9M
Total debt	$14.4M
Total liabilities	$55.8M
WACC	8.54%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.27
Current assets	$157.6M
Current liabilities	$38.3M
Current ratio	4.12
Inventory turnover	4.79
Net working capital	$52.6M
Quick ratio	3.37
Working capital	$119.3M
Working capital turnover	3.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.83%
Dividend yield	0%
Shareholder yield	3.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	37.03%
10Y return CAGR	3.2%
10Y total return	37.03%
150-day SMA	$25.07
1D price change	1.79%
1M price change	5.5%
1M total return	5.5%
1W price change	1.96%
1W total return	1.96%
1Y price change	59.87%
1Y return CAGR	59.92%
1Y total return	59.87%
20-day SMA	$22.79
200-day SMA	$25.93
3M price change	-13.62%
3M total return	-13.62%
3Y price change	117.6%
3Y return CAGR	29.58%
3Y total return	117.6%
50-day SMA	$22.73
50-day SMA vs 200-day SMA	50under200
52-week high	$37.77
52-week high date	2026-02-18
52-week low	$14.84
52-week low date	2025-10-31
5Y price change	-29.47%
5Y return CAGR	-6.75%
5Y total return	-29.47%
6M price change	-1.07%
6M total return	-1.07%
All-time high	$76.63
All-time high date	2019-02-20
All-time low	$6.28
All-time low date	2022-06-13
Average true range (ATR)	$0.65
Average volume	190.1K
Beta (1Y)	-0.38
Beta (2Y)	0.69
Beta (5Y)	0.82
Change from 52-week high	-36.78%
Change from 52-week low	60.92%
Change from all-time high	-68.71%
Change from all-time low	281.85%
Change from open	-0.04%
Day's gap	1.83%
Dollar volume	$2.4M
High price	$23.91
Low price	$23.83
Monthly RSI	54.25
Open price	$23.89
Position in 52-week range	62.5%
Previous close	$23.46
Price vs 150-day SMA	-4.34%
Price vs 20-day SMA	5.24%
Price vs 200-day SMA	-7.52%
Price vs 50-day SMA	5.49%
Relative volume	0.52
RSI	60.81
Sharpe ratio	0.97
Sharpe ratio (3Y)	0.65
Sharpe ratio (5Y)	0.1
Sortino ratio	2.01
Sortino ratio (3Y)	1.15
Sortino ratio (5Y)	0.25
Volume	99.2K
Weekly RSI	48.86
YTD price change	-17.31%
YTD total return	-17.31%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20.6M
Float percentage	90.85%
Shares change (QoQ)	2.21%
Shares change (YoY)	-3.83%
Shares held by insiders	2.16%
Shares held by institutions	91.48%
Shares outstanding	22.7M
Short % of float	13.85%
Short % of shares	12.58%
Short ratio	10.1 days

Deeper analysis on TCMD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TCMD report

Is a complete TCMD research report available?

No complete published report is available for Tactile Systems Technology, Inc. (TCMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Tactile Systems Technology, Inc. (TCMD)

Price

Financial snapshot

Fair-value bridge

Latest news · TCMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TCMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TCMD

Frequently asked questions